This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brent, T. P. Articles by Bigner, D. D. Search for Related Content PubMed Articles by Brent, T. P. Articles by Bigner, D. D.

Immunoaffinity Purification of Human O⁶-Alkylguanine-DNA Alkyltransferase Using Newly Developed Monoclonal Antibodies¹

Department of Biochemical and Clinical Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101, and Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710

As well as repairing mutagenic lesions induced by simple methylating agents, O⁶-alkylguanine-DNA alkyltransferase repairs precursors of cytotoxic interstrand cross-links induced by chloroethylating anticancer drugs. Moreover, levels of the transferase correlate with cellular resistance to these agents. Thus far, the human transferase has not been highly purified. In our quest to obtain the homogeneous protein we have produced four stable cloned hybridomas that secrete monoclonal antibodies against the alkyltransferase from human lymphoblasts. The specificity of these monoclonals was established by immunoblot analysis and immunoprecipitation. All these antibodies recognized the alkyltransferase only after its denaturation by sodium dodecyl sulfate. One of them, designated 19.2, was used in immunoaffinity chromatography to obtain the pure protein.

¹ This work was supported by Grants CA 14799, CA 36888, CA 21765, CA 11898, and NS 20023 from the NIH and by the American Lebanese Syrian Associated Charities.

Received 6/ 5/89. Revised 9/ 5/89. Accepted 10/ 3/89.

This article has been cited by other articles:

				S Uccella, R Cerutti, C Placidi, S Marchet, I Carnevali, B Bernasconi, I Proserpio, G Pinotti, M G Tibiletti, D Furlan, et al. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression J. Clin. Pathol., August 1, 2009; 62(8): 715 - 723. [Abstract] [Full Text] [PDF]

				J. A. Maxwell, S. P. Johnson, J. A. Quinn, R. E. McLendon, F. Ali-Osman, A. H. Friedman, J. E. Herndon II, K. Bierau, J. Bigley, D. D. Bigner, et al. Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma. Mol. Cancer Ther., October 1, 2006; 5(10): 2531 - 2539. [Abstract] [Full Text] [PDF]

				I. F. Pollack, R. L. Hamilton, R. W. Sobol, J. Burnham, A. J. Yates, E. J. Holmes, T. Zhou, and J. L. Finlay O6-Methylguanine-DNA Methyltransferase Expression Strongly Correlates With Outcome in Childhood Malignant Gliomas: Results From the CCG-945 Cohort J. Clin. Oncol., July 20, 2006; 24(21): 3431 - 3437. [Abstract] [Full Text] [PDF]

				L. Shen, Y. Kondo, G. L. Rosner, L. Xiao, N. S. Hernandez, J. Vilaythong, P. S. Houlihan, R. S. Krouse, A. R. Prasad, J. G. Einspahr, et al. MGMT Promoter Methylation and Field Defect in Sporadic Colorectal Cancer J Natl Cancer Inst, September 21, 2005; 97(18): 1330 - 1338. [Abstract] [Full Text] [PDF]

				M. D. Bacolod, S. P. Johnson, A. E. Pegg, M. E. Dolan, R. C. Moschel, N. S. Bullock, Q. Fang, O. M. Colvin, P. Modrich, D. D. Bigner, et al. Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations Mol. Cancer Ther., September 1, 2004; 3(9): 1127 - 1135. [Abstract] [Full Text] [PDF]

				S. L. Gerson Clinical Relevance of MGMT in the Treatment of Cancer J. Clin. Oncol., May 1, 2002; 20(9): 2388 - 2399. [Abstract] [Full Text] [PDF]

				M. Esteller, G. Gaidano, S. N. Goodman, V. Zagonel, D. Capello, B. Botto, D. Rossi, A. Gloghini, U. Vitolo, A. Carbone, et al. Hypermethylation of the DNA Repair Gene O6-Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma J Natl Cancer Inst, January 2, 2002; 94(1): 26 - 32. [Abstract] [Full Text] [PDF]

				P. Wolf, Y. C. Hu, K. Doffek, D. Sidransky, and S. A. Ahrendt O6-Methylguanine-DNA Methyltransferase Promoter Hypermethylation Shifts the p53 Mutational Spectrum in Non-Small Cell Lung Cancer Cancer Res., November 1, 2001; 61(22): 8113 - 8117. [Abstract] [Full Text] [PDF]

				K. S. Srivenugopal, J. Shou, S. R. S. Mullapudi, F. F. Lang Jr., J. S. Rao, and F. Ali-Osman Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents Clin. Cancer Res., May 1, 2001; 7(5): 1398 - 1409. [Abstract] [Full Text]

				M. Esteller, S. R. Hamilton, P. C. Burger, S. B. Baylin, and J. G. Herman Inactivation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation is a Common Event in Primary Human Neoplasia Cancer Res., February 1, 1999; 59(4): 793 - 797. [Abstract] [Full Text] [PDF]

				L. Liu, X. Qin, and S. L. Gerson Reduced lung tumorigenesis in human methylguanine DNA—methyltransferase transgenic mice achieved by expression of transgene within the target cell Carcinogenesis, February 1, 1999; 20(2): 279 - 284. [Abstract] [Full Text] [PDF]

				Z.-P. Chen, A. Malapetsa, A. McQuillan, D. Marcantonio, V. Bello, G. Mohr, J. Remack, T. P. Brent, and L. C. Panasci Evidence for Nucleotide Excision Repair as a Modifying Factor of O6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines Mol. Pharmacol., November 1, 1997; 52(5): 815 - 820. [Abstract] [Full Text]

				F. Y. Chen, L. C. Harris, J. S. Remack, and T. P. Brent Cytoplasmic sequestration of an O6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells PNAS, April 29, 1997; 94(9): 4348 - 4353. [Abstract] [Full Text] [PDF]

				J. S. Reese, O. N. Koc, K. M. Lee, L. Liu, J. A. Allay, W. P. Phillips Jr., and S. L. Gerson Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea PNAS, November 26, 1996; 93(24): 14088 - 14093. [Abstract] [Full Text] [PDF]